Back to search

Article

Cholesterol-Modified Anti-Il6 siRNA Reduces the Severity of Acute Lung Injury in Mice

2024-04-18

Abstract excerpt

Small interfering RNA (siRNA) holds significant therapeutic potential by silencing target genes through RNA interference. Current clinical applications of siRNA have been primarily limited to liver diseases, while achievements in delivery methods are expanding its applications to various organs, including the lungs. Cholesterol-conjugated siRNA emerges as a promising delivery approach due to its low toxicity and h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
52cbbba1-12f9-59fd-b82c-449f51701974
DOI
10.20944/preprints202404.1195.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cholesterol-Modified Anti-Il6 siRNA Reduces the Severity of Acute Lung Injury in MiceDOI 10.20944/preprints202404.1195.v1
Select a neighboring publication to make it the new centre.